Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$69.35
-3.0%
$64.87
$28.81
▼
$77.00
$221.92M0.1250,625 shs10,817 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.20
-6.3%
$3.00
$2.66
▼
$5.49
$52.59M1.18104,760 shs43,722 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
+2.33%+12.69%+13.31%+5.29%+112.70%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+3.33%+4.92%+16.38%+7.91%-19.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$69.35
-3.0%
$64.87
$28.81
▼
$77.00
$221.92M0.1250,625 shs10,817 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.20
-6.3%
$3.00
$2.66
▼
$5.49
$52.59M1.18104,760 shs43,722 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
+2.33%+12.69%+13.31%+5.29%+112.70%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+3.33%+4.92%+16.38%+7.91%-19.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2.67
Moderate Buy$74.006.71% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.60
Moderate Buy$5.8382.58% Upside

Current Analyst Ratings Breakdown

Latest SRTS and PDEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/10/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+) ➝ Buy (B-)
11/9/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeStrong-Buy ➝ Hold
10/23/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B) ➝ Hold (C+)
10/8/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+) ➝ Buy (B)
9/21/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B-) ➝ Hold (C+)
9/15/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold ➝ Strong-Buy
9/11/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Boost Price TargetBuy$70.00 ➝ $74.00
9/4/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+) ➝ Buy (B-)
8/24/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B-) ➝ Hold (C+)
8/18/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
DowngradeSell (D) ➝ Sell (D-)
8/17/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingBuy
(Data available from 11/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$77.55M2.86$3.87 per share17.90$15.42 per share4.50
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$27.48M1.91N/AN/A$2.93 per share1.09
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$13.66M$3.6519.0020.64N/A15.12%26.18%16.69%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.94N/AN/AN/A-88.45%-21.57%-19.20%11/12/2026 (Estimated)

Latest SRTS and PDEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.0550N/AN/AN/A$6.61 millionN/A
10/29/2026Q1 2027
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.92+$0.25$0.92$20.40 million$20.56 million
9/3/2026Q4 2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.87+$0.20$0.87$19.20 million$20.41 million
8/13/2026Q2 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250-$0.53-$0.4050-$0.53$4.60 million$2.29 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.25
4.19
2.49
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.71
4.30

Institutional Ownership

CompanyInstitutional Ownership
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
48.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2063.20 million1.66 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
6016.46 million14.78 millionOptionable

Recent News About These Companies

Sensus Healthcare收涨3.33%,成交额23.51万美元
Sensus Healthcare收涨3.77%,成交额51.32万美元
Sensus Healthcare收涨11.19%,成交额38.78万美元
Sensus Healthcare收跌10.15%,成交额43.12万美元
Sensus Healthcare (SRTS) Set to Post Quarterly Earnings on Thursday
Sensus Healthcare收跌1.07%,成交额160.87万美元
Sensus Healthcare收跌0.36%,成交额3.69万美元
Sensus Healthcare收跌1.77%,成交额4.88万美元
Sensus Healthcare收跌1.06%,成交额16.79万美元
Sensus Healthcare收涨1.08%,成交额28.2万美元
Sensus Healthcare收跌4.41%,成交额5.5万美元
Sensus Healthcare收涨2.79%,成交额3.69万美元
Sensus Healthcare收涨0.35%,成交额2.98万美元
Sensus Healthcare收跌0.36%,成交额14.08万美元
Sensus Healthcare收跌0.36%,成交额6.83万美元
Sensus Healthcare收平,成交额3.56万美元

New MarketBeat Followers Over Time

Media Sentiment Over Time

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$69.33 -2.16 (-3.02%)
As of 02:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.19 -0.22 (-6.45%)
As of 02:35 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.